Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Knox Pharmaceuticals is an international pharmaceutical wholesaler and distributor headquartered in Ripon, United Kingdom, with a significant regional presence in Lagos, Nigeria. Established in 1995, the company specializes in the global supply of branded and generic pharmaceutical products, including anti-malarials, anti-infectives, anti-hypertensives, and multivitamins. Knox Pharmaceuticals operates as a key intermediary in the healthcare supply chain, serving hospitals, clinics, and pharmacies across the UK, Europe, and Sub-Saharan Africa. The company is licensed by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and the Home Office, ensuring all products are distributed in compliance with Good Distribution Practice (GDP) standards. With a focus on accessibility and quality, Knox Pharmaceuticals leverages its logistical expertise to provide essential medicines to emerging markets, particularly in West Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Knox Pharmaceutical.